Meghann Leclair, | |
3 Centre Dr, Milton, VT 05468-3779 | |
(802) 893-7459 | |
(802) 893-6938 |
Full Name | Meghann Leclair |
---|---|
Gender | Female |
Speciality | Pharmacist |
Location | 3 Centre Dr, Milton, Vermont |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1689047524 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 033.0094487 (Vermont) | Primary |
Mailing Address | Practice Location Address |
---|---|
Meghann Leclair, 3 Centre Dr, Milton, VT 05468-3779 Ph: () - | Meghann Leclair, 3 Centre Dr, Milton, VT 05468-3779 Ph: (802) 893-7459 |
News Archive
Child development can be vastly improved by providing pregnant women and caregivers of children with an integrated intervention that consists of improved water, sanitation, hygiene (WASH), nutrition, mental health care and lead exposure prevention, says a study conducted in Bangladesh.
Currently more than 10% of preschoolers in the U.S. are obese and effective strategies that target pregnancy, infancy, and toddlers are urgently needed to stop the progression of the childhood obesity epidemic, as proposed in an article in Childhood Obesity, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
Abbott today presented 48-week findings comparing an HIV regimen of its protease inhibitor (PI), Kaletra® (lopinavir/ritonavir), and Merck's integrase inhibitor, Isentress® (raltegravir), to a traditional HIV regimen of Kaletra and the nucleotide/nucleoside reverse transcriptase inhibitors (NRTIs) in Truvada® (tenofovir and emtricitabine) in antiretroviral-naive adult patients. Efficacy data were collected over the first 48 weeks of the 96-week PROGRESS (PROtease/InteGRasE Simplification Study) study.
Alliance Medical Products announced today, at the AAPS Annual Meeting and Exposition, the U.S. Food and Drug Administration (FDA) has granted approval to manufacture a certain commercially available ophthalmic product using the company's high speed dropper bottle filling line.
Sequencing the genomes of tumor cells has revealed thousands of mutations associated with cancer. One way to discover the role of these mutations is to breed a strain of mice that carry the genetic flaw — but breeding such mice is an expensive, time-consuming process.
› Verified 5 days ago
Joseph A Rampe, BS.PHARM Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 201 Us Rt 7 South, Milton, VT 05468 Phone: 802-893-2717 Fax: 802-893-7351 | |
Dr. Tyler King, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 259 Route 7 S, Milton, VT 05468 Phone: 802-893-0714 | |
Kelly Cross, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 201 Us Rt 7, Milton, VT 05468 Phone: 802-893-2717 | |
Jeremy Scott, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3 Centre Dr, Milton, VT 05468 Phone: 802-893-7459 | |
Dr. Marie-michele Wilcox, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 201 Us Route 7, Milton, VT 05468 Phone: 802-893-2717 | |
Michelle Lynn Wakerley, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 259 Us Route 7 S, Milton, VT 05468 Phone: 802-893-0714 |